{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T16:38:50Z","timestamp":1774283930801,"version":"3.50.1"},"reference-count":54,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2017,9,7]],"date-time":"2017-09-07T00:00:00Z","timestamp":1504742400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Australia-China International Collaborative Grant","award":["NH&MRC-APP1112767-NSFC81561128020"],"award-info":[{"award-number":["NH&MRC-APP1112767-NSFC81561128020"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinical &amp; Translational Med"],"published-print":{"date-parts":[[2017,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Type II diabetes mellitus (T2DM) is complicated by multiple cardio\u2010metabolic risk factors. Controlling these factors requires lifestyle modifications alongside utilisation of anti\u2010diabetic medications. Different glucose lowering [(biguanides (BIGs), sulfonylureas (SUAs), thiazolidinediones (TNZ)], lipid lowering (statins), and anti\u2010hypertensive medicines [angiotensin converting enzyme inhibitors (ACEIs), calcium channel blockers (CCBs), angiotensin II receptor blockers (ARBs) and central acting drugs (CADs)] have been approved for controlling hyperglycaemia, dyslipidaemia and hypertension respectively. Here, we examined factors that characterise T2DM and explored the response to medication therapy among T2DM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This prospective cohort study recruited 241 T2DM patients reporting at a clinic in Ghana, from January through to August, 2016. Each patient's demographic, medications and anthropometric data was obtained while information on medication adherence was captured using Morisky adherence scale\u20108 (MMAS\u20108). Fasting blood samples were collected for biochemical analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean age of participants was 57.82 years for baseline and six\u2010month follow\u2010up. Physical activity differed at baseline and follow up (p &lt; 0.05) but not body mass index (BMI). BIG alone, or in combination with SUA and TNZ did not improve glycaemic status at follow up (p &gt; 0.05). Many participants using either ACEI or ARB were able to control their blood pressures. Among dyslipidaemia patients under statin treatment, there was an improved lipid profile at follow\u2010up.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Statin medications are effective for reducing dyslipidaemia in T2DM patients. However, control of modifiable risk factors, particularly blood glucose and to a lesser degree blood pressure is suboptimal. Addressing these will require concomitant interventions including education on medication adherence and correct dietary plans, lifestyle modifications and physical activity.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s40169-017-0162-5","type":"journal-article","created":{"date-parts":[[2017,8,8]],"date-time":"2017-08-08T13:57:23Z","timestamp":1502200643000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Profiling of cardio\u2010metabolic risk factors and medication utilisation among Type II diabetes patients in Ghana: a prospective cohort study"],"prefix":"10.1002","volume":"6","author":[{"given":"Eric","family":"Adua","sequence":"first","affiliation":[{"name":"School of Medical and Health Sciences Edith Cowan University 270 Joondalup Drive 6027 Joondalup, Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Roberts","sequence":"additional","affiliation":[{"name":"School of Medical and Health Sciences Edith Cowan University 270 Joondalup Drive 6027 Joondalup, Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel Asamoah","family":"Sakyi","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis Agyemang","family":"Yeboah","sequence":"additional","affiliation":[{"name":"Department of Molecular Medicine Kwame Nkrumah University of Science and Technology Kumasi Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert","family":"Dompreh","sequence":"additional","affiliation":[{"name":"Department of Serology Komfo Anokye Teaching Hospital Kumasi Ghana"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kwasi","family":"Frimpong","sequence":"additional","affiliation":[{"name":"School of Medical and Health Sciences Edith Cowan University 270 Joondalup Drive 6027 Joondalup, Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enoch Odame","family":"Anto","sequence":"additional","affiliation":[{"name":"School of Medical and Health Sciences Edith Cowan University 270 Joondalup Drive 6027 Joondalup, Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Wang","sequence":"additional","affiliation":[{"name":"School of Medical and Health Sciences Edith Cowan University 270 Joondalup Drive 6027 Joondalup, Perth WA Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,9,7]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105033441801"},{"key":"e_1_2_7_3_1","unstructured":"International Diabetes Federation:IDF Diabetes Atlas2015.http:\/\/www.diabetesatlas.org\/resources\/2015\u2010atlas.html. Accessed 04 Oct 2016"},{"key":"e_1_2_7_4_1","unstructured":"The World Health Organisation:The Diabetes epidemiology2014.http:\/\/www.who.int\/mediacentre\/factsheets\/fs312\/en\/accessed. Accessed 14 Feb 2015"},{"issue":"4","key":"e_1_2_7_5_1","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM199907223410406","article-title":"Glucose transporters and insulin action\u2014implications for insulin resistance and diabetes mellitus","volume":"341","author":"Epstein FH","year":"1999","journal-title":"N Engl J Med"},{"issue":"210","key":"e_1_2_7_6_1","first-page":"1","article-title":"Diabetes mellitus type 2 in urban Ghana: characteristics and associated factors","volume":"12","author":"Danquah I","year":"2012","journal-title":"BMC Public Health"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.2011.93"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.53.082901.103904"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.26.5.1435"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-014-0491-3"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11920-010-0165-z"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0802743"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0036-4"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-016-0775-x"},{"issue":"2","key":"e_1_2_7_15_1","doi-asserted-by":"crossref","first-page":"S185","DOI":"10.3233\/JAD-2012-111433","article-title":"Type 2 diabetes and cognitive impairment: linking mechanisms","volume":"30","author":"Luchsinger JA","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.321.7258.405"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-005-1858-4"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2013.09.012"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2014.09.011"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.12.1734"},{"issue":"6","key":"e_1_2_7_21_1","first-page":"e007571","article-title":"The correlation between blood pressure and kidney function decline in older people: a registry\u2010based cohort study","volume":"5","author":"Vaes B","year":"2015","journal-title":"BMJ"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.HYP.0000178102.85718.66"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-S062"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-008-1157-y"},{"issue":"2","key":"e_1_2_7_25_1","doi-asserted-by":"crossref","first-page":"S202","DOI":"10.2337\/dc11-s221","article-title":"Type 2 diabetes can be prevented with early pharmacological intervention","volume":"34","author":"DeFronzo RA","year":"2011","journal-title":"Diabetes Care"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-013-0374-z"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2010.01255.x"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158499"},{"key":"e_1_2_7_29_1","unstructured":"The World Health Organization.Definition diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation.1999.http:\/\/www.staff.ncl.ac.uk\/philip.home\/who_dmg.pdf. Accessed 01 May 2017"},{"key":"e_1_2_7_30_1","first-page":"151","article-title":"Guidelines for the management of hypertension. Guidelines Subcommittee","volume":"17","author":"World Health Organization","year":"1999","journal-title":"J Hypertens"},{"key":"e_1_2_7_31_1","first-page":"2486","article-title":"Executive summary of the third report of The National Cholesterol Education Program","volume":"285","author":"Expert Panel on Detection, Treatment of High Blood Cholesterol In Adults","year":"2001","journal-title":"JAMA"},{"issue":"3","key":"e_1_2_7_32_1","doi-asserted-by":"crossref","first-page":"2","DOI":"10.15212\/FMCH.2016.0116","article-title":"The global reach of family medicine and community health","volume":"4","author":"Wang W","year":"2016","journal-title":"Fam Med Community Health"},{"key":"e_1_2_7_33_1","doi-asserted-by":"crossref","unstructured":"AduaE FrimpongK LiX WangW(2017)Emerging issues in public health: a perspective 5 on Ghana\u2019s healthcare expenditure policies and outcomes. EPMA J. doi:https:\/\/doi.org\/10.1007\/s13167\u2010017\u20100109\u20103","DOI":"10.1007\/s13167-017-0109-3"},{"key":"e_1_2_7_34_1","doi-asserted-by":"crossref","first-page":"37","DOI":"10.15212\/FMCH.2016.0102","article-title":"Integration of community health workers into health systems in developing countries: opportunities and challenges","volume":"14","author":"Asweto CO","year":"2016","journal-title":"Fam Med Community Health"},{"key":"e_1_2_7_35_1","first-page":"1","article-title":"West meets east: Chinese and US doctors addressing the medical ecology and disease management from both countries\u2019 perspectives","volume":"3","author":"Wang W","year":"2011","journal-title":"Fam Med Community Health"},{"key":"e_1_2_7_36_1","first-page":"S11","article-title":"Standards of medical care in diabetes\u20102015 summary of revisions","volume":"38","author":"American Diabetes Association","year":"2015","journal-title":"Diabetes Care"},{"key":"e_1_2_7_37_1","unstructured":"World Health Organisation 2006.Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia.http:\/\/apps.who.int\/iris\/bitstream\/10665\/43588\/1\/9241594934_eng.pdf"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11883-008-0081-4"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1177\/14746514030030010901"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2014.05.001"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1464-5491.2002.00689.x"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.25.9.1612"},{"key":"e_1_2_7_43_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-015-0056-z"},{"key":"e_1_2_7_44_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5868-8-115"},{"key":"e_1_2_7_45_1","doi-asserted-by":"publisher","DOI":"10.1017\/S000711451400052X"},{"key":"e_1_2_7_46_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-015-3585-9"},{"key":"e_1_2_7_47_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-5949.2011.00264.x"},{"key":"e_1_2_7_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)04311-6"},{"key":"e_1_2_7_49_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.884"},{"key":"e_1_2_7_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2008.09.047"},{"issue":"1","key":"e_1_2_7_51_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1475-2840-10-31","article-title":"Trends in utilization of lipid\u2010and blood pressure\u2010lowering agents and goal attainment among the US diabetic population, 1999\u20132008","volume":"10","author":"Kuznik A","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"e_1_2_7_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0149-2918(01)80109-0"},{"key":"e_1_2_7_53_1","first-page":"153","volume-title":"An introduction to medicinal chemistry","author":"Patrick GL","year":"2013"},{"key":"e_1_2_7_54_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21019\/9781582121260","volume-title":"Handbook of basic pharmacokinetics\u2014including clinical applications","author":"Ritschel WA","year":"2009"},{"issue":"2","key":"e_1_2_7_55_1","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.2337\/dc11-s216","article-title":"The pros and cons of diagnosing diabetes with A1C","volume":"34","author":"Bonora E","year":"2011","journal-title":"Diabetes Care"}],"container-title":["Clinical and Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1186\/s40169-017-0162-5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40169-017-0162-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1186%2Fs40169-017-0162-5","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1186\/s40169-017-0162-5","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40169-017-0162-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1186\/s40169-017-0162-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,6]],"date-time":"2023-09-06T04:02:25Z","timestamp":1693972945000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1186\/s40169-017-0162-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9,7]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["10.1186\/s40169-017-0162-5"],"URL":"https:\/\/doi.org\/10.1186\/s40169-017-0162-5","archive":["Portico"],"relation":{},"ISSN":["2001-1326","2001-1326"],"issn-type":[{"value":"2001-1326","type":"print"},{"value":"2001-1326","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,9,7]]},"article-number":"e32"}}